Bayer CropScience Ltd

Bayer Crop Sci. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Bayer CropScience Ltd

₹ 4,001 0.39%
24 Mar - close price
bayer.in BSE: 506285 NSE : BAYERCROP
About

Bayer CropScience is engaged in Agri Care business which primarily includes manufacture, sale and distribution of insecticides, fungicides, herbicide and various other agrochemical products and corn seeds.[1]

Key Points

Business Areas

Website BSE NSE
  • Market Cap ₹ 17,979 Cr.
  • Current Price ₹ 4,001
  • High / Low ₹ 5,668 / 3,949
  • Stock P/E 26.5
  • Book Value ₹ 641
  • Dividend Yield 2.50 %
  • ROCE 30.9 %
  • ROE 23.7 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 77.6%

Cons

  • The company has delivered a poor sales growth of 11.0% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Multinational

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022
854 459 1,228 1,382 918 734 1,416 1,365 990 963 1,667 1,452 1,038
694 400 902 1,084 812 651 1,094 1,143 924 763 1,272 1,214 952
Operating Profit 160 58 325 298 106 83 322 222 66 201 395 238 85
OPM % 19% 13% 26% 22% 12% 11% 23% 16% 7% 21% 24% 16% 8%
22 -11 14 15 18 22 15 14 68 16 14 14 116
Interest 4 3 3 2 4 4 2 2 3 6 4 8 3
Depreciation 15 19 24 14 14 22 15 14 14 21 23 15 14
Profit before tax 164 26 313 296 106 80 320 220 118 190 382 229 184
Tax % 16% -23% 19% 24% 143% 22% 21% 30% 28% 19% 21% 29% 27%
Net Profit 138 32 252 225 -45 62 254 154 85 153 303 163 134
EPS in Rs 30.68 7.01 56.01 49.98 -10.04 13.77 56.45 34.29 18.87 33.98 67.33 36.18 29.93
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 TTM
2,097 2,233 2,682 3,188 3,660 2,769 2,803 2,710 3,167 3,609 4,261 4,734 5,120
1,874 1,980 2,321 2,768 3,144 2,334 2,389 2,300 2,684 2,883 3,450 3,923 4,201
Operating Profit 223 254 362 419 516 435 414 410 483 726 812 812 919
OPM % 11% 11% 13% 13% 14% 16% 15% 15% 15% 20% 19% 17% 18%
17 -14 1,242 91 88 82 70 39 51 -64 69 112 160
Interest 8 2 4 5 5 10 7 11 10 14 13 13 20
Depreciation 33 34 37 65 25 25 29 33 44 65 74 64 74
Profit before tax 199 204 1,563 441 574 482 448 404 480 583 794 847 984
Tax % 34% 32% 26% 34% 33% 35% 35% 26% 30% 19% 38% 24%
Net Profit 132 139 1,162 290 383 315 291 300 337 474 493 645 752
EPS in Rs 33.32 35.19 294.11 79.06 104.59 89.13 82.31 87.41 98.18 105.58 109.72 143.58 167.42
Dividend Payout % 12% 12% 2% 7% 20% 19% 21% 21% 18% 24% 105% 104%
Compounded Sales Growth
10 Years: 8%
5 Years: 11%
3 Years: 14%
TTM: 14%
Compounded Profit Growth
10 Years: 13%
5 Years: 16%
3 Years: 21%
TTM: 34%
Stock Price CAGR
10 Years: 13%
5 Years: -1%
3 Years: 8%
1 Year: -14%
Return on Equity
10 Years: 19%
5 Years: 20%
3 Years: 22%
Last Year: 24%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Sep 2022
40 40 40 37 37 35 35 34 34 45 45 45 45
Reserves 634 753 1,892 1,706 1,996 1,804 2,021 1,744 2,205 2,528 2,505 2,479 2,834
108 0 0 0 0 0 0 0 0 2 26 86 83
778 1,048 484 645 740 597 769 756 1,310 1,262 1,663 1,742 1,668
Total Liabilities 1,560 1,841 2,415 2,387 2,773 2,437 2,825 2,535 3,549 3,836 4,239 4,353 4,630
348 248 219 228 322 290 342 334 440 468 425 468 560
CWIP 6 9 127 217 1 17 24 36 47 56 76 98 14
Investments 4 4 4 4 29 68 50 0 0 41 52 38 39
1,202 1,580 2,066 1,939 2,422 2,062 2,410 2,164 3,062 3,270 3,686 3,749 4,017
Total Assets 1,560 1,841 2,415 2,387 2,773 2,437 2,825 2,535 3,549 3,836 4,239 4,353 4,630

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
122 107 138 282 200 206 157 121 433 666 687 216
195 88 427 -290 485 16 -8 38 -113 -29 7 64
-32 -128 -21 -480 -42 -590 -73 -581 -158 -148 -556 -703
Net Cash Flow 285 67 544 -488 644 -367 76 -421 162 489 138 -424

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Debtor Days 49 42 44 47 57 53 72 89 81 73 65 77
Inventory Days 119 128 106 98 85 169 178 175 294 206 226 235
Days Payable 80 67 42 51 40 52 67 67 164 101 142 127
Cash Conversion Cycle 88 103 108 94 102 171 184 197 211 177 149 185
Working Capital Days 46 9 79 88 53 92 104 134 116 77 62 87
ROCE % 29% 34% 29% 24% 31% 25% 23% 22% 25% 30% 31% 31%

Shareholding Pattern

Numbers in percentages

Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022
71.43 71.43 71.43 71.43 71.43 71.43 71.43 71.43 71.43 71.43 71.44 71.44
2.17 2.34 2.79 2.60 2.87 2.97 3.05 2.99 2.90 2.95 3.10 3.19
13.86 13.56 12.63 12.47 12.49 11.34 12.23 12.53 12.90 13.10 12.76 12.78
12.53 12.67 13.15 13.50 13.21 14.26 13.28 13.05 12.77 12.51 12.71 12.59

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls